All In Biotech

Drug Trial Radar · NCT03228680

Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Japanese Women

A Randomised, Controlled, Assessor-blind, Parallel Groups, Multicentre Trial Assessing the Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Japanese Women Undergoing an Assisted Reproductive Technology Programme

Last checked: Nov 19, 2026Latest source record: Aug 24, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 373 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

373

Actual

Start

Jul 29, 2017

Primary completion

Jun 10, 2019

Study completion Jul 8, 2019

Sponsor

Lead sponsor
Ferring PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Jul 25, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Female only, from 20 years, up to 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To demonstrate non-inferiority of FE 999049 compared to FOLLISTIM with respect to number of oocytes retrieved in Japanese IVF/ICSI patients undergoing controlled ovarian stimulation.

Conditions

  • Infertility

Interventions

  • Follitropin deltaDrug

    Single daily subcutaneous administration through pre-filled injection pen

  • Follitropin betaDrug

    Single daily subcutaneous injection in the abdomen

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Oocytes RetrievedTime frame: 36h (± 2h) after triggering of final follicular maturation (On day of oocyte retrieval)

Locations

17 sites in 1 country. Site status is shown where the registry gives one.

  • Akita University Hospital

    Akita, Japan

  • Yamashita Ladies' Clinic

    Hyōgo, Japan

  • Investigational Site 8126

    Saitama, Japan

  • Omiya Ladies Clinic

    Saitama, Japan

  • Saint Women's Clinic

    Saitama, Japan

  • Women's Clinic Fujimino

    Saitama, Japan

  • Tokushima University Hospital

    Tokushima, Japan

  • Yachiyo Hospital

    Anjo, Aichi-ken, Japan

  • Investigational Site 8121

    Chiba, Chiba, Japan

  • Yokota Maternity Hospital

    Maebashi, Gunma, Japan

  • Sophia Ladies Clinic

    Sagamihara, Kanagawa, Japan

  • Investigational Site 8122

    Sendai, Miyagi, Japan

  • Investigational Site 8123

    Higashiōsaka-shi, Osaka, Japan

  • Investigational Site 8120

    Osaka, Osaka, Japan

  • Ladies Clinic Kitahama

    Osaka, Osaka, Japan

  • Investigational Site 8125

    Saitama-shi, Saitama, Japan

  • Investigational Site 8124

    Shinjuku-Ku, Tokyo, Japan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.